impact factor
logo
 

Letters to the Editor

 

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren’s syndrome


1, 2, 3, 4, 5, 6

 

  1. Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Melbourne, Australia. fabien.vincent@monash.edu
  2. Rheumatology Department, The Queen Elizabeth Hospital, Woodville, Australia.
  3. Rheumatology Department, The Queen Elizabeth Hospital, Woodville, Australia.
  4. Dept. of Immunology and Pathology, Monash Univ., Alfred Medical Research and Education Precinct (AMREP); and Dept. of Microbiology and Immunology, School of Biomedical Sciences, Dentistry & Health Sciences, Univ. of Melbourne, Australia.
  5. Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Melbourne, Australia.
  6. Rheumatology Department, The Queen Elizabeth Hospital, Woodville, and Discipline of Medicine, University of Adelaide, Australia.

CER11741
2019 Vol.37, N°3 ,Suppl.118
PI 0254, PF 0256
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 30789150 [PubMed]

Received: 14/09/2018
Accepted : 03/12/2018
In Press: 15/02/2019
Published: 28/08/2019

Rheumatology Article

Rheumatology Addendum